Evidence map›Paper›PMID 37296153›Full record

ArticleNature communications2023

Asymptomatic immunodeficiency-associated vaccine-derived poliovirus infections in two UK children.

Anika Singanayagam, Dimitra Klapsa, Shirelle Burton-Fanning, Julian Hand, Thomas Wilton, Laura Stephens, Ryan Mate, Benjamin Shillitoe, Cristina Celma, Mary Slatter and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Current infectious disease management challenges in inborn errors of immunity.Annals of clinical microbiology and antimicrobials · 2025
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Anika SinganayagamPolio Reference Service, UK Health Security Agency, Colindale, London, UK. anika.singanayagam@ukhsa.gov.uk.ORCID 0000-0002-2572-0173
Dimitra KlapsaDivision of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, London, UK.
Shirelle Burton-FanningMicrobiology and Virology Services, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Julian HandPolio Reference Service, UK Health Security Agency, Colindale, London, UK.
Thomas WiltonDivision of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, London, UK.
Laura StephensDivision of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, London, UK.
Ryan MateDivision of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, London, UK.
Benjamin ShillitoePaediatric Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle upon Tyne, UK.ORCID 0000-0003-4407-5998
Cristina CelmaPolio Reference Service, UK Health Security Agency, Colindale, London, UK.ORCID 0000-0003-2223-5057
Mary SlatterPaediatric Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle upon Tyne, UK.
Terry FloodPaediatric Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle upon Tyne, UK.
Robin GopalPolio Reference Service, UK Health Security Agency, Colindale, London, UK.
Javier MartinDivision of Vaccines, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, London, UK.ORCID 0000-0001-5326-7081
Maria ZambonPolio Reference Service, UK Health Security Agency, Colindale, London, UK. maria.zambon@ukhsa.gov.uk.
National Institute for Biological Standards and Control · GBUK Health Security Agency · GBGreat North Children's Hospital · GBPublic Health England · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBSheffield Children's NHS Foundation Trust · GB

Funding

Department of Health
6 · The paper itself

Abstract

Increasing detections of vaccine-derived poliovirus (VDPV) globally, including in countries previously declared polio free, is a public health emergency of international concern. Individuals with primary immunodeficiency (PID) can excrete polioviruses for prolonged periods, which could act as a source of cryptic transmission of viruses with potential to cause neurological disease. Here, we report on the detection of immunodeficiency-associated VDPVs (iVDPV) from two asymptomatic male PID children in the UK in 2019. The first child cleared poliovirus with increased doses of intravenous immunoglobulin, the second child following haematopoetic stem cell transplantation. We perform genetic and phenotypic characterisation of the infecting strains, demonstrating intra-host evolution and a neurovirulent phenotype in transgenic mice. Our findings highlight a pressing need to strengthen polio surveillance. Systematic collection of stool from asymptomatic PID patients who are at high risk for poliovirus excretion could improve the ability to detect and contain iVDPVs.

Indexed as

Immunologic Deficiency SyndromesPoliomyelitisPoliovirusPoliovirus Vaccine, OralAnimalsMaleMiceUnited KingdomPoliovirus Vaccine, Oral

Identifiers

PMID37296153
PMCPMC10251316
OpenAlexW4379986091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.